Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 200,000 | reported | 21 Jan 2009 | tx 27+426,822−79,817 |
| PROTEIN DESIGN LABS INC/DE | 126,050 | reported | 20 Jun 2019 | tx 5+340,240 |
| Protagonist Therapeutics, Inc | 90,000 | reported | 26 Feb 2021 | tx 7+299,500 |
| Tonix Pharmaceuticals Holding Corp. | 20,000 | reported | 12 Jun 2018 | tx 23+519,533−168,817 |
| DEPOMED INC | 3,131 | reported | 18 May 2016 | tx 10+95,308−1,700 |
| Auspex Pharmaceuticals, Inc. | 0 | reported | 05 May 2015 | tx 9+47,175−195,127 |
| Trubion Pharmaceuticals, Inc | 0 | reported | 28 Oct 2010 | tx 8+15,000−39,135 |
| SRKP 4 INC | 0 | reported | 03 Jul 2009 | tx 2+45,000−45,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2021 | GRANT_AWARD | Protagonist Therapeutics, Inc | 12,000 | 0.00 USD | |
| 26 Feb 2021 | GRANT_AWARD | Protagonist Therapeutics, Inc | 90,000 | 0.00 USD | deriv |
| 28 Feb 2020 | GRANT_AWARD | Protagonist Therapeutics, Inc | 85,000 | 0.00 USD | deriv |
| 20 Jun 2019 | GRANT_AWARD | PROTEIN DESIGN LABS INC/DE | 126,050 | 3.00 USD | deriv |
| 15 May 2019 | GRANT_AWARD | Protagonist Therapeutics, Inc | 45,000 | 0.00 USD | deriv |
| 28 Feb 2019 | GRANT_AWARD | Protagonist Therapeutics, Inc | 2,500 | 0.00 USD | |
| 28 Feb 2019 | GRANT_AWARD | Protagonist Therapeutics, Inc | 15,000 | 0.00 USD | deriv |
| 12 Jun 2018 | GRANT_AWARD | Tonix Pharmaceuticals Holding Corp. | 20,000 | 0.00 USD | deriv |
| 08 Jun 2018 | GRANT_AWARD | PROTEIN DESIGN LABS INC/DE | 54,348 | 2.76 USD | |
| 31 May 2018 | GRANT_AWARD | Protagonist Therapeutics, Inc | 50,000 | 0.00 USD | deriv |
| 25 Feb 2016 | EXERCISE | Tonix Pharmaceuticals Holding Corp. | 600 | 0.00 USD | |
| 09 Feb 2017 | EXERCISE | Tonix Pharmaceuticals Holding Corp. | 750 | 0.00 USD | |
| 27 May 2017 | EXERCISE | Tonix Pharmaceuticals Holding Corp. | 750 | 0.00 USD | |
| 27 May 2017 | EXERCISE | Tonix Pharmaceuticals Holding Corp. | 750 | 0.00 USD | deriv |
| 09 Feb 2017 | EXERCISE | Tonix Pharmaceuticals Holding Corp. | 750 | 0.00 USD | deriv |
| 25 Feb 2016 | EXERCISE | Tonix Pharmaceuticals Holding Corp. | 650 | 0.00 USD | deriv |
| 20 Jun 2017 | GRANT_AWARD | Tonix Pharmaceuticals Holding Corp. | 20,000 | 0.00 USD | deriv |
| 09 Jun 2017 | GRANT_AWARD | PROTEIN DESIGN LABS INC/DE | 60,729 | 2.47 USD | |
| 21 Jun 2016 | PURCHASE | Tonix Pharmaceuticals Holding Corp. | 25,000 | 2.00 USD | |
| 02 Jun 2016 | GRANT_AWARD | PROTEIN DESIGN LABS INC/DE | 71,023 | 3.52 USD | |
| 27 May 2016 | GRANT_AWARD | Tonix Pharmaceuticals Holding Corp. | 7,500 | 0.00 USD | deriv |
| 18 May 2016 | GRANT_AWARD | DEPOMED INC | 3,131 | 0.00 USD | deriv |
| 18 May 2016 | GRANT_AWARD | DEPOMED INC | 7,669 | 0.00 USD | deriv |
| 12 May 2016 | TAX_WITHHOLDING | DEPOMED INC | 734 | 17.52 USD | |
| 09 Feb 2016 | GRANT_AWARD | Tonix Pharmaceuticals Holding Corp. | 7,500 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 17 Jul 2015.